Asthma and once-daily administration of inhaled corticosteroids: potential for improved compliance and reduced health costs

R. B. Coambs, J. L. Jarry, A. H. Rattray, B. S. Ferguson, J. Witt, F. G. De Maio, R. Abrahamsohn, A. Santhiapillai (Toronto, Canada)

Source: Annual Congress 2002 - Steroid and other anti-inflammatory agents
Session: Steroid and other anti-inflammatory agents
Session type: Thematic Poster Session
Number: 1918
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. B. Coambs, J. L. Jarry, A. H. Rattray, B. S. Ferguson, J. Witt, F. G. De Maio, R. Abrahamsohn, A. Santhiapillai (Toronto, Canada). Asthma and once-daily administration of inhaled corticosteroids: potential for improved compliance and reduced health costs. Eur Respir J 2002; 20: Suppl. 38, 1918

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease
Source: Eur Respir J 2003 Dec 01;22(6):912-919
Year: 2003



Considerations about cost-effectiveness and global satisfaction of asthmatic patients treated with montelukast compared with inhaled corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 42s
Year: 2002

Once per day inhaled corticosteroids: a method to improve compliance and asthma control
Source: Eur Respir J 2001; 18: Suppl. 33, 441s
Year: 2001

Comparative efficacy and costs of the treatment of moderate to severe persistent asthma with a new dry-powder inhaled beclomethasone dipropionate and formoterol combination
Source: Annual Congress 2013 –Health economics of airway diseases
Year: 2013


Asthma control in general practice with inhaled corticosteroids and long-acting B2-agonists administered as a fixed or free combination at stable dosage: the ALISE survey
Source: Eur Respir J 2002; 20: Suppl. 38, 397s
Year: 2002

Integrating high dose inhaled corticosteroids into oral corticosteroids stewardship
Source: Eur Respir J, 55 (1) 1902193; 10.1183/13993003.02193-2019
Year: 2020



Addition of leukotriene antagonists or long-acting β2-agonists to inhaled corticosteroid therapy in asthma treatment increases drug costs without decreasing service-related costs
Source: Eur Respir J 2001; 18: Suppl. 33, 262s
Year: 2001

The effect of smoking on severity of asthma and quality of life in patients treated with inhaled corticosteroids and long-acting b2-agonist (ICS/LABA)
Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD
Year: 2012

Feedback on inhaler use does not significantly improve inhaled corticosteroid adherence or clinical outcomes
Source: Virtual Congress 2020 – Digital technologies in airway diseases
Year: 2020




Budesonide/formoterol reduces the use of oral corticosteroids in the treatment of COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 50s
Year: 2003

Concomitant use of long-acting beta-agonists with inhaled corticosteroids among asthma patients in the UK primary care
Source: Annual Congress 2007 - Miscellaneous epidemiological aspects of respiratory disease
Year: 2007


Regular use of inhaled corticosteroids and the long-term prevention of hospitalisation for asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 8s
Year: 2002

Efficacy and safety of inhaled corticosteroids in combination with a long-acting beta2-agonist in asthmatic children under age 5
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016


Optimal adherence with inhaled corticosteroids is related to better health status
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015


Modelling the beneficial impact of inhaled corticosteroids on health outcomes among COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 290s
Year: 2004

Prescribed doses and effect on asthma treatment outcomes of extrafine (ciclesonide) vs standard particle inhaled corticosteroids (ICS)
Source: International Congress 2015 – Novel targets and strategies for the treatment of cough, asthma, rhinosinusitis and COPD
Year: 2015

Quality of life of patients with asthma exacerbations treated with high doses of inhaled corticosteroids
Source: Eur Respir J 2002; 20: Suppl. 38, 114s
Year: 2002

Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials
Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs
Year: 2013

Efficacy and safety of high-dose inhaled corticosteroids therapy in children with asthma
Source: Annual Congress 2010 - Allergy and risk factors in paediatrics
Year: 2010


Step-up of asthma therapy: an observational study comparing increased inhaled corticosteroid dosage to combination inhaled corticosteroid/long acting beta agonist therapy in UK general practice
Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control
Year: 2007